Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Association between dietary niacin intake and Helicobacter pylori seropositivity in US adults: A cross-sectional study

  • Zeru Chen,

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – original draft, Writing – review & editing

    Affiliations Department of Clinical Laboratory Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China, Department of Clinical Medicine, The Second School of Clinical Medicine, Guangzhou Medical University, Guangzhou, China

    ⨯
  • Shixin Wu,

    Roles Methodology, Supervision, Writing – original draft, Writing – review & editing

    Affiliations Department of Clinical Laboratory Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China, Department of Preventative Medicine, School of Public Health, Guangzhou Medical University, Guangzhou, China

    ⨯
  • Guangzhan Chen,

    Roles Investigation, Software, Validation, Visualization, Writing – review & editing

    Affiliations Department of Clinical Laboratory Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China, Department of Clinical Medicine, The Sixth School of Clinical Medicine, Guangzhou Medical University, Guangzhou, China

    ⨯
  • Xuguang Guo

    Roles Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Writing – review & editing

    gysygxg@gmail.com

    Affiliations Department of Clinical Laboratory Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China, Department of Clinical Medicine, The Third School of Clinical Medicine, Guangzhou Medical University, Guangzhou, China, Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, King Med School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, China

    ⨯

Abstract

Objectives

This study delves into the association between dietary niacin intake and Helicobacter pylori seropositivity, a topic gaining prominence in academic discourse. However, the precise role of Niacin in the development and progression of Helicobacter pylori seropositivity remains inadequately understood. Thus, this research aims to investigate the connections between H. pylori seropositivity and dietary niacin intake using a nationally representative sample of adults.

Methods

A cross-sectional analysis encompassed 4,000 participants from the National Health and Nutrition Examination Survey (NHANES) conducted in the United States between 1999 and 2000, all aged 20 years or older. The study employed the generalized additive model (GAM) and multivariate logistic regression to explore the potential relationship between niacin intake and Helicobacter pylori seropositivity. Subgroup analyses were performed based on gender, age, diabetes, hypertension, and hyperlipemia.

Results

Analyzing cross-sectional data from NHANES 1999–2000 involving individuals aged 20 years and above revealed that out of 4,000 participants, 1,842 tested positive for H. pylori via serology. Multivariate analyses unveiled a significant inverse correlation between niacin intake and H. pylori seropositivity. Adjusted odds ratios (ORs) for dietary niacin intake in quartiles Q2 (13.31–19.26 mg/d), Q3 (19.27–27.42 mg/d), and Q4 (>27.42 mg/d) compared to Q1 (<13.31 mg/d) were 0.83 (95% CI: 0.69–1.01), 0.74 (95% CI: 0.61–0.90), and 0.66 (95% CI: 0.54–0.81), respectively. Moreover, a nonlinear L-shaped relationship (P = 0.022) emerged between niacin intake and H. pylori seropositivity, indicating minimal risk of H. pylori infection at approximately 44.69 mg of niacin per day in the diet.

Conclusion

This study suggests a potential link between increased dietary niacin intake and reduced prevalence of Helicobacter pylori seropositivity. This correlation is bolstered by plausible mechanisms involving immunomodulatory function, mitochondrial dysfunction, and cellular oxidative stress.

Citation: Chen Z, Wu S, Chen G, Guo X (2024) Association between dietary niacin intake and Helicobacter pylori seropositivity in US adults: A cross-sectional study. PLoS ONE 19(8): e0308686. https://doi.org/10.1371/journal.pone.0308686

Editor: Ahmad Salimi, School of Pharmacy, Ardabil University of Medical Sciences, ISLAMIC REPUBLIC OF IRAN

Received: December 28, 2023; Accepted: July 29, 2024; Published: August 15, 2024

Copyright: © 2024 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and its Supporting Information files.

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

1. Introduction

Helicobacter pylori, often referred to as H. pylori, is a spiral-shaped, gram-negative bacterium known for colonizing the human stomach’s mucosa [1]. It’s significantly linked to gastrointestinal conditions like gastritis, peptic ulcers, and gastric cancer [2]. Despite extensive research, it remains prevalent, affecting an estimated 4.4 billion people globally in 2015, imposing a substantial burden on public health systems, highlighting the urgency for preventive strategies [3, 4]. Recent studies exploring dietary influences on H. pylori infection suggest potential preventive dietary interventions, albeit with specific components requiring further investigation [5–7].

Niacin, also known as vitamin B3, is a water-soluble B vitamin found in various foods and supplements [8], derived from both plant and animal sources such as fortified cereals, meats, and vegetables [9]. Its role in NAD-related diseases has expanded its perceived function beyond being solely a vitamin, prompting exploration into potential therapeutic applications [10]. As a precursor of NAD and NADP [11], nicotinic acid serves as a crucial cofactor in mitochondrial energy metabolism [10]. Its deficiency can impede oxidative phosphorylation and disrupt mitochondrial respiration [12]. Clinical investigations suggest that increasing niacin intake through diet may enhance immunity and potentially reduce the colonization of H. pylori [13–16]. Previous studies have indicated that mitochondrial dysfunction, oxidative stress, and immune modulation may influence the pathogenesis and progression of H. pylori infection [17–19]. However, there is a lack of comprehensive and sizable cross-sectional research exploring the potential correlation between dietary niacin intake and the presence of H. pylori antibodies.

Therefore, this study aims to fill this gap by examining the relationship between dietary niacin consumption and H. pylori seropositivity using the extensive National Health and Nutrition Examination Survey (NHANES) database. Understanding this connection could unveil new paths for preventing H. pylori infection.

2. Methods

2.1 Date sources and study design

This study utilized a cross-sectional research approach, drawing on data from the NHANES, a comprehensive, multistage, stratified, and complex survey conducted nationally by the Centers for Disease Control and Prevention (CDC) [20]. NHANES provides demographic information, dietary assessments, health interviews, physical exams, and laboratory tests for the US ambulatory population [21, 22]. Participants’ dietary status was evaluated through two-day, 24-hour dietary recalls, while physical examinations and blood samples were collected at a mobile examination center (MEC). Detailed information about the survey and associated research data is available on the NHANES website at https://www.cdc.gov/nchs/nhanes/.

The survey employed the 1999–2000 US NHANES dataset. Initially comprising 9,965 eligible participants, the study excluded 2,472 due to incomplete H.p data, 288 due to incomplete dietary niacin data, and 3,205 under the age of 20. Ultimately, 4,000 participants were included. The flowchart in Fig 1 outlines the sample selection process. The 1999–2000 NHANES protocol was approved by the National Center for Health Statistics Research Ethics Review Board. Before participating in the study, all subjects provided informed written consent [23]. Our study rigorously adhered to the protocols outlined by the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) criteria [24].

thumbnail
Download:
Fig 1. Flowchart detailing the selection process for patients included in this analysis.

https://doi.org/10.1371/journal.pone.0308686.g001

2.2 Dietary niacin intake

The study on dietary niacin intake involved face-to-face interviews at the Mobile Examination Center (MEC) [25]. Eligible NHANES participants underwent two 24-hour dietary recall interviews, initially at the MEC conducted by trained personnel and followed up 3 to 10 days later via phone or mail [26, 27]. The dietary recall method used in NHANES is designed to capture detailed information on all foods and beverages consumed by the participants within the past 24 hours. This method ensures comprehensive dietary data collection, which is then processed and validated by NHANES staff.

Nutrient analysis utilized the U.S. Department of Agriculture’s Food and Nutritional Dietary Studies Database (FNDDS). The dataset summarized individual nutrient intake, with niacin intake calculated as the average of the two dietary reviews. Niacin intake, including supplementation, was assessed following NHANES guidelines. Categorization into quartiles (Q1–Q4) and continuous variables represented different levels of intake, with critical values at 25%, 50%, and 75% of the total sample niacin intake. Quartiles were delineated as Q1 (<13.31 mg/day), Q2 (13.31–19.26 mg/day), Q3 (19.27–27.42 mg/day), and Q4 (>27.42 mg/day).

2.3 Helicobacter pylori antibody measurement

Helicobacter pylori antibody levels were measured using an enzyme-linked immunosorbent assay (ELISA) for H. pylori IgG by Wampole Laboratory in Cranbury, NJ [28]. Immunological status ratios (ISR) were calculated by dividing the average cutoff value by the average optical density (OD) of the test sample [29]. Ratio Diagnostics in Frankfurt, Germany, developed the ELISA for qualitative detection and measurement of H. pylori IgG antibodies in human blood. The serum anti-H. pylori assay determined specific antibody titers, with levels above 0.9 indicating positive infection in this study [30].

2.4 Covariates

Covariates, chosen based on clinical expertise and previous literature [31–33], encompassed age, gender, education, body mass index (BMI), poverty-to-income ratio (PIR), marital status, smoking and alcohol status, diabetes, and cardiovascular disease indicators. Gender was categorized as male or female, education as below high school, high school, or above high school, and marital status as married/cohabiting or living alone [34]. Alcohol and smoking patterns were treated as binary variables, defined respectively as consuming at least 12 drinks per year and classifying never smokers as those who never smoked or smoked fewer than 100 cigarettes in their lifetime [35]. BMI categories were established as normal weight (BMI <25 kg/m2), overweight (BMI ≥25, <30 kg/m2), and obese (BMI ≥30 kg/m2) [36]. Diabetes was identified in participants with a past or current diagnosis [37], while cardiovascular disease was determined based on reported history [38]. Specific data on serum albumin, total cholesterol, creatinine, and C-reactive protein (CRP) were extracted from NHANES laboratory test results.

2.5 Statistical analysis

The R statistical package (version 3.6.3; R Foundation) and EmpowerStats program (version 4.1) were utilized for data analysis. Weighted percentages were applied to categorical variables, while descriptive analyses for continuous variables involved averages, standard deviations (SD), or median and quartile range (QR) to characterize the study population. Kruskal-Wallis and chi-square tests assessed statistical significance for continuous and categorical variables, respectively. The association between dietary niacin intake and Helicobacter pylori (H. pylori) infection was indicated by OR values.

Multifactorial logistic regression explored this association, creating a corrected model accounting for included covariates. Trends were identified through quartile median calculations. Model 1 adjusted for age, sex, marital status, education, and PIR. Model 2 was fully adjusted, encompassing blood cardiovascular disease, smoking, drinking, diabetes, body mass index, and serological indices (CRP, creatinine, total cholesterol, and albumin). Dietary niacin intake was analyzed as both continuous and categorical variables in multivariate logistic regression, categorizing niacin intake into Q1 (<13.31 mg/day), Q2 (13.31–19.26 mg/day), Q3 (19.27–27.42 mg/day), and Q4 (>27.42 mg/day), with Q1 as the reference group.

Addressing the non-linear correlation, a generalized additive model with smooth curve fitting was used, alongside a recursive algorithm and two-stage logistic model to determine the inflection point. Interaction analysis involved likelihood ratio tests and hierarchical logistic regression among age, gender, diabetes, hypertension, and hyperlipemia subgroups. The Wald statistic tested trend variable heterogeneity, while cross-product terms determined subgroup membership. A two-sided p-value <0.05 indicated statistical significance with 95% confidence intervals. The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) declaration for cross-sectional studies.

3. Result

3.1 Baseline characteristics population

The study utilized NHANES data from 1999 to 2000. After applying strict exclusion criteria (e.g., missing H. pylori data, unknown dietary niacin intake, age <20 years), a final cohort of 4,000 participants underwent analysis. Fig 1 visually represents the study outcomes and specific exclusion criteria.

Univariate analyses revealed associations between H. pylori seropositivity and variables such as age, sex, education, poverty-to-income ratio (PIR), body mass index (BMI), alcohol use, diabetes mellitus, serum albumin, heart failure, cardiac assault, and niacin intake (S1 Table).

Table 1 displays the descriptive characteristics of participants. Among the 1,842 individuals with H. pylori infection, the average age was 49.8 years, and 46.8% were male. Notably, this group differed from the H. pylori seronegative group in various aspects: lower niacin intake, higher age, lower education and income levels, increased BMI, elevated serum c-reactive protein levels, higher diabetes mellitus prevalence, and increased occurrences of hypertension, heart failure and heart attack. Furthermore, the H. pylori seropositive group had a higher proportion of non-alcohol users compared to the seronegative group.

thumbnail
Download:
Table 1. The baseline characteristics and demographic characteristics of the study population (N = 4000).

https://doi.org/10.1371/journal.pone.0308686.t001

3.2 The connection between dietary niacin intake and H.p seropositivity

In examining the association between niacin intake as a continuous variable and H. pylori seropositivity, a notable inverse relationship was observed. Each 1 mg/d increase in niacin intake was significantly associated with a reduced chance of H. pylori seropositivity across all models—unadjusted, model 1, and model 2—yielding consistent odds ratios (OR) of 0.98 (95% CI 0.98–0.99), 0.99 (95% CI 0.98–0.99), and 0.99 (95% CI 0.98–0.99) respectively, indicating a robust correlation between higher niacin intake and decreased H. pylori seropositivity.

Furthermore, when niacin intake was categorized into quartiles and adjusted for various demographic and health-related variables, a substantial inverse association between dietary niacin consumption and H. pylori seropositivity was established. Compared to individuals with lower niacin consumption (Q1, <13.31 mg/day), those in Q2 (13.31–19.26 mg/day), Q3 (19.26–27.42 mg/day), and Q4 (>27.42 mg/day) displayed adjusted OR values of 0.83 (95% CI: 0.69–1.00, p = 0.0600), 0.74 (95% CI: 0.61–0.90, p = 0.0028), and 0.66 (95% CI: 0.54–0.81, p < 0.0001) respectively (Table 2). Notably, trend tests confirmed the statistical significance of the overall decreasing trend in H. pylori seropositivity with increasing dietary niacin intake (p<0.0001).

thumbnail
Download:
Table 2. Multivariable logistic regression to assess the association of niacin intake with Helicobacter pylori seropositivity.

https://doi.org/10.1371/journal.pone.0308686.t002

3.3 Dose-response relationships

The study investigated dietary niacin intake as a continuous variable. A significant non-linear relationship (p = 0.022) resembling an "L" shape was observed between dietary niacin intake and H. pylori seropositivity, as revealed by multivariate-adjusted restricted triple spline analysis (Fig 2). Through graphical analysis and clinical relevance, the optimal inflection point for niacin intake was determined to be 44.69 mg/day. Among individuals consuming less than 44.69 mg of niacin daily, a 1 mg/day increase in niacin corresponded to a 2.0% reduction in H. pylori infection risk (CI: 0.98 [0.97–0.99]; p < 0.0001). Table 3 illustrates that there was no significant association for niacin intakes equal to or greater than 44.69 mg/day (odds ratio [OR], CI: 1.01 [1.00–1.03]; p = 0.1476).

thumbnail
Download:
Fig 2. Dose–response relationship between dietary niacin intake and Helicobacter pylori seropositivity odds ratio.

Solid and dashed lines represent the predicted value and 95% confidence intervals. Adjusted for age, gender, marital status, poverty-income ratio, education, body mass index, cardiovascular disease (hypertension, hyperlipemia, heartfailure, coronary heart disease, angina, and heart attack), smoking, alcohol, diabetes, and serum indicators (CRP, albumin, total cholesterol, and creatinine). Only 99% of the data is shown. H.p, Helicobacter pylori; CI, confidence interval; OR, odds ratios; Ref, reference.

https://doi.org/10.1371/journal.pone.0308686.g002

thumbnail
Download:
Table 3. Threshold effect analysis of relationship of niacin intake and Helicobacter pylori seropositivity.

https://doi.org/10.1371/journal.pone.0308686.t003

3.4 Subgroup analysis

Using subgroup analyses, the effects of various risk factors on the relationship between niacin intake and seropositivity against H.p were investigated. Gender, age, diabetes, hypertension, and hyperlipemia were considered for stratification. An analysis of subgroups and interaction is shown in Fig 3, which was in line with the findings of multivariate logistic regression.

thumbnail
Download:
Fig 3. Subgroup analysis association between dietary niacin intake and Helicobacter pylori seropositivity.

Adjusted for age, gender, marital status, poverty income ratio, education, body mass index, cardiovascular disease (hypertension, hyperlipemia, heartfailure, coronary heart disease, angina, and heart attack), smoking, alcohol, diabetes, and serum indicators (CRP, albumin, total cholesterol, and creatinine). Hp, Helicobacter pylori; CI, confidence interval; OR, odds ratios; Ref, reference.

https://doi.org/10.1371/journal.pone.0308686.g003

4. Discussion

Our study reveals that higher niacin intake significantly reduces H. pylori positivity, especially in the upper quartiles (Q3, Q4) compared to the lowest (Q1). Even after accounting for confounding factors, this relationship remains significant. Interestingly, we identified an "L" shaped association between niacin intake and H. pylori antibodies, with a turning point at 44.69 mg/day. Below this threshold, H. pylori seroprevalence decreases with increased niacin intake, but no notable association exists at or above this level.

This discovery offers a new perspective for the non-pharmacological prevention of H. pylori infection. Although antibiotic treatment is the current standard method for managing H. pylori infection, treatment failures, recurrences, and increasing antibiotic resistance necessitate the search for alternative preventive and management strategies. Against this backdrop, our research suggests that increasing dietary niacin intake may serve as an effective preventive measure. Specifically, dietary adjustments to increase the intake of niacin-rich foods, such as meats, fish, whole grains, and legumes, can help reduce the risk of H. pylori infection. Furthermore, the promotion and implementation of this strategy could have a positive impact on public health policies. By enhancing public awareness of the role of diet and nutrition in preventing H. pylori infection, healthy eating habits can be promoted, thereby reducing the incidence of infection on a broader scale. Additionally, targeted dietary interventions for high-risk groups, such as individuals with a family history of H.pylori-related diseases, could further reduce infection risks among these populations.

This investigation represents the first exploration of the link between dietary niacin consumption and H. pylori seropositivity using a cross-sectional approach. While few studies directly address this relationship, pertinent research contributes valuable contextual understanding. Population-based retrospective cohort analysis and meta-analyses indicate that individuals with periodontitis exhibit higher rates of gastric H. pylori infection compared to those without this condition [15, 16]. Furthermore, existing research consistently supports a strong link between reduced niacin intake and the development of periodontitis, often associated with compromised immune function, elevating susceptibility to bacterial infections in the oral cavity [13, 14, 39]. Given niacin’s role in maintaining a healthy immune system, augmenting dietary niacin intake might enhance the body’s immune response and potentially reduce the likelihood of H. pylori colonization [40]. This suggests a plausible association between niacin and susceptibility to H. pylori.

The exact biological mechanisms delineating the inverse correlation between dietary niacin intake and seropositivity for H.pylori remain partly veiled. However, the corpus of existing evidence substantiates the biological plausibility of our discoveries. Mitochondrial toxicity possibly correlates with the underlying mechanism of H. pylori infection. Research precedent elucidates that the VacA toxin, secreted by H. pylori, significantly enhances the bacterium’s colonization efficiency in the stomach [41–43]. Investigation conducted by Eiki Yamasaki [44] reveals that VacA precipitates a decline in the mitochondrial transmembrane potential, thereby triggering mitochondrial toxicity. Moreover, the mitochondrial dysfunction and energy deficiency induced by VacA facilitate a more effective colonization of H. pylori on gastric epithelial cells [17, 45]. These findings suggest that mitochondrial dysfunction and energy shortage, as a result of VacA-induced mitochondrial toxicity, are pivotal in the infection process of H. pylori. It is noteworthy that increasing the intake of NAD might help alleviate conditions such as reduced mitochondrial membrane potential, decreased ATP synthesis, and energy deficiency caused by VacA [46]. Given that niacin is primarily present in the diet in the form of NAD [47], therefore, increasing dietary niacin intake to boost NAD levels could potentially counteract the mitochondrial toxicity induced by the VacA toxin, thereby reducing the risk of H. pylori infection.

Moreover, a potential correlation exists between H. pylori infection and oxidative stress. Previous studies have demonstrated that H. pylori strains can form biofilms on the surface of the gastric mucosa [48, 49]. Once formed, the biofilm can provide protection for H. pylori, helping it to survive in the gastric environment for a long time, shielded from disinfection and sterilization [18]. Bacteria’s stress response and subsequent biofilm formation can be facilitated by low concentrations of reactive oxygen species (ROS) in vivo [50]. Niacin acts as a precursor to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), crucial in cellular functioning and oxidative stress regulation [10]. Studies have demonstrated that elevated niacin concentrations effectively inhibit reactive oxygen species (ROS) formation [51], and suppress superoxide production by directly reducing electron transfer [52]. Given niacin’s observed impact on cellular oxidative stress, it’s plausible to hypothesize a potential link between niacin consumption and the occurrence or progression of H. pylori infection. Niacin’s effect on cellular oxidative stress may specifically inhibit H. pylori survival or proliferation by suppressing ROS production, impeding Hp strain biofilm formation, and their adaptation to the gastric environment.

The immune modulation potentially associated with H. pylori infection involves niacin’s activation of GPR109A receptors in monocytes and macrophages, promoting CD8(+) T-cell proliferation [53]. This suggests a supplementary role for niacin in modulating immune cell functionality. Additionally, GPR109A activation in immune cells significantly influences inflammatory responses [54]. Niacin has demonstrated efficacy in reducing pro-inflammatory cytokine expression (e.g., TNFα and IL-6) in human monocytes activated by LPS and mouse macrophages [53, 55]. IL-6, secreted by macrophages in response to pathogen-associated molecular patterns (PAMPs), interacts with pattern recognition receptors (PRRs), particularly Toll-like receptors (TLRs), which hold importance in H. pylori infection [19, 56]. Hence, niacin’s modulation of immune cell function might aid in preventing H. pylori infection.

While our hypotheses stem from plausible mechanisms, further empirical studies specifically exploring the niacin-H. pylori association are needed. Investigating niacin’s impact on H. pylori colonization, survival, and the gastric environment is crucial for validating these hypotheses.

Our study’s strengths lie in its substantial cohort of 4000 participants from NHANES, a nationally representative database known for meticulous surveys and stringent quality control, ensuring high-quality data. It pioneers research on niacin intake’s link to Helicobacter pylori seropositivity, highlighting the novelty and significance of our work. Diverse methodological approaches, including dose-response curves and smoothing function analysis, fortified our findings, revealing an intriguing L-shaped relationship between dietary niacin intake and H. pylori seropositivity.

Although our research has some unique advantages, we must acknowledge that it also has certain limitations. First, this is an observational study, and despite our efforts to adjust for various confounding factors, we cannot entirely exclude the possibility of residual confounding due to unmeasured variables. Hence, our study design cannot establish causality. Second, there may be recall bias or inaccuracies in self-reporting in the two 24-hour dietary recall interviews. Moreover, our study was unable to directly measure biomarkers such as mitochondrial toxicity, limiting our ability to deeply understand the mechanisms of niacin’s action. Looking ahead, We will conduct prospective cohorts or a more complicated experimental design in future research to directly measure biomarkers related to mitochondrial function, in order to validate the effects of niacin on H.pylori infection and its potential mechanisms. Lastly, this study focused solely on the American population, which limits the generality of the results to other populations. Therefore, future research needs to be conducted in a more diverse population to verify whether our findings are universally applicable.

5. Conclusion

Our findings highlight a significant inverse relationship between dietary niacin intake and H. pylori seropositivity, supported by plausible mechanisms involving immunomodulatory function, mitochondrial dysfunction, and cellular oxidative stress regulation. While our study enriches comprehension of this connection, additional direct investigations are crucial to confirm and elaborate on these initial findings, potentially presenting innovative approaches for managing H. pylori infections.

Supporting information

S1 Table. Univariate logistic regression to assess the association of niacin intake with Helicobacter pylori seropositivity.

Abbreviations: %, weighted proportion; Hp:Helicobacter pylori,CRP; C-reactive protein. Cardiovascular disease (heartfailure, coronary heart disease, angina, heart attack, stroke). CI: confidence interval;OR:odds ratios,Ref: reference.

https://doi.org/10.1371/journal.pone.0308686.s001

(DOCX)

S1 Raw data.

https://doi.org/10.1371/journal.pone.0308686.s002

(CSV)

Acknowledgments

We appreciate Dr. Kai Zhang of the Cardiovascular Surgery Department of Jilin University Second Hospital for statistics, study design consultations, and editing the manuscript.

References

  1. 1. Pellicano R, Ribaldone DG, Fagoonee S, Astegiano M, Saracco GM, Mégraud F. A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva medica. 2016;58(4):304–17. Epub 2016/10/08. pmid:27716738.
  2. 2. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30. Epub 2016/11/02. pmid:27707777.
  3. 3. Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. The lancet Gastroenterology & hepatology. 2023;8(6):553–64. Epub 2023/04/23. pmid:37086739.
  4. 4. Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Alimentary pharmacology & therapeutics. 2018;47(7):868–76. Epub 2018/02/13. pmid:29430669.
  5. 5. Rueda-Robles A, Rubio-Tomás T, Plaza-Diaz J, Álvarez-Mercado AI. Impact of Dietary Patterns on H. pylori Infection and the Modulation of Microbiota to Counteract Its Effect. A Narrative Review. Pathogens (Basel, Switzerland). 2021;10(7). Epub 2021/08/07. pmid:34358024; PubMed Central PMCID: PMC8308520.
  6. 6. Xia Y, Meng G, Zhang Q, Liu L, Wu H, Shi H, et al. Dietary Patterns are Associated with Helicobacter Pylori Infection in Chinese Adults: A Cross-Sectional Study. Scientific reports. 2016;6:32334. Epub 2016/08/31. pmid:27573193; PubMed Central PMCID: PMC5004161.
  7. 7. Habbash F, Alalwan TA, Perna S, Ahmed N, Sharif O, Al Sayyad A, et al. Association between Dietary Habits and Helicobacter pylori Infection among Bahraini Adults. Nutrients. 2022;14(19). Epub 2022/10/15. pmid:36235867; PubMed Central PMCID: PMC9572631.
  8. 8. Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annual review of nutrition. 2008;28:115–30. Epub 2008/04/24. pmid:18429699.
  9. 9. Mielgo-Ayuso J, Aparicio-Ugarriza R, Olza J, Aranceta-Bartrina J, Gil Á, Ortega RM, et al. Dietary Intake and Food Sources of Niacin, Riboflavin, Thiamin and Vitamin B₆ in a Representative Sample of the Spanish Population. The Anthropometry, Intake, and Energy Balance in Spain (ANIBES) Study †. Nutrients. 2018;10(7). Epub 2018/07/04. pmid:29966236; PubMed Central PMCID: PMC6073544.
  10. 10. Kirkland JB, Meyer-Ficca ML. Niacin. Advances in food and nutrition research. 2018;83:83–149. Epub 2018/02/27. pmid:29477227.
  11. 11. Afzal M, Kuipers OP, Shafeeq S. Niacin-mediated Gene Expression and Role of NiaR as a Transcriptional Repressor of niaX, nadC, and pnuC in Streptococcus pneumoniae. Frontiers in cellular and infection microbiology. 2017;7:70. Epub 2017/03/25. pmid:28337428; PubMed Central PMCID: PMC5343564.
  12. 12. Pirinen E, Auranen M, Khan NA, Brilhante V, Urho N, Pessia A, et al. Niacin Cures Systemic NAD(+) Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell metabolism. 2020;31(6):1078–90.e5. Epub 2020/05/11. pmid:32386566.
  13. 13. Lee JH, Lee SA, Kim HD. Periodontitis and intake of thiamine, riboflavin and niacin among Korean adults. Community dentistry and oral epidemiology. 2020;48(1):21–31. Epub 2019/10/05. pmid:31583741.
  14. 14. Park JA, Lee JH, Lee HJ, Jin BH, Bae KH. Association of Some Vitamins and Minerals with Periodontitis in a Nationally Representative Sample of Korean Young Adults. Biological trace element research. 2017;178(2):171–9. Epub 2016/12/31. pmid:28035581.
  15. 15. Moradi Y, Majidi L, Khateri S, Azh N, Gheshlagh RG, Saniee N, et al. The association between periodontal diseases and helicobacter pylori: an updated meta-analysis of observational studies. BMC oral health. 2023;23(1):523. Epub 2023/07/27. pmid:37496045; PubMed Central PMCID: PMC10369707.
  16. 16. Li X, Chaouhan HS, Li CH, Yu TM, Wang IK, Lin CL, et al. Higher Risk of Gastric Helicobacter pylori Infection in Patients with Periodontitis: A Nationwide Population-Based Retrospective Cohort Study in Taiwan. International journal of environmental research and public health. 2021;18(21). Epub 2021/11/14. pmid:34770192; PubMed Central PMCID: PMC8583388.
  17. 17. Seeger AY, Zaidi F, Alhayek S, Jones RM, Zohair H, Holland RL, et al. Host cell sensing and restoration of mitochondrial function and metabolism within Helicobacter pylori VacA intoxicated cells. mBio. 2023;14(5):e0211723. Epub 2023/10/10. pmid:37815365; PubMed Central PMCID: PMC10653863.
  18. 18. Zhao Y, Cai Y, Chen Z, Li H, Xu Z, Li W, et al. SpoT-mediated NapA upregulation promotes oxidative stress-induced Helicobacter pylori biofilm formation and confers multidrug resistance. Antimicrobial agents and chemotherapy. 2023;65(5). Epub 2021/03/03. pmid:33649116; PubMed Central PMCID: PMC8092859.
  19. 19. Lee CYQ, Chan YT, Cheok YY, Tan GMY, Tang TF, Cheong HC, et al. Helicobacter pylori Infection Elicits Type I Interferon Response in Human Monocytes via Toll-Like Receptor 8 Signaling. Journal of immunology research. 2022;2022:3861518. Epub 2022/11/02. pmid:36317079; PubMed Central PMCID: PMC9617731.
  20. 20. Bailey RL, Pac SG, Fulgoni VL 3rd, Reidy KC, Catalano PM. Estimation of Total Usual Dietary Intakes of Pregnant Women in the United States. JAMA network open. 2019;2(6):e195967. Epub 2019/06/22. pmid:31225890; PubMed Central PMCID: PMC6593963 Nutrition Impact LLC, Nestle/Gerber, RTI International, and the National Institutes of Health Office of Dietary Supplements. Dr Fulgoni, as Senior Vice President of Nutrition Impact LLC, reported performing consulting and database analyses for various food and beverage companies and related entities. Ms Pac and Dr Reidy reported being employees of Nestle Nutrition. No other disclosures were reported.
  21. 21. Chung S, Chung MY, Choi HK, Park JH, Hwang JT, Joung H. Animal Protein Intake Is Positively Associated with Metabolic Syndrome Risk Factors in Middle-Aged Korean Men. Nutrients. 2020;12(11). Epub 2020/11/12. pmid:33172198; PubMed Central PMCID: PMC7694953.
  22. 22. Wei J, Wang L, Kulshreshtha A, Xu H. Adherence to Life’s Simple 7 and Cognitive Function Among Older Adults: The National Health and Nutrition Examination Survey 2011 to 2014. Journal of the American Heart Association. 2022;11(6):e022959. Epub 2022/03/05. pmid:35243896; PubMed Central PMCID: PMC9075323.
  23. 23. Fang Zhang F, Liu J, Rehm CD, Wilde P, Mande JR, Mozaffarian D. Trends and Disparities in Diet Quality Among US Adults by Supplemental Nutrition Assistance Program Participation Status. JAMA network open. 2018;1(2):e180237. Epub 2018/12/01. pmid:30498812; PubMed Central PMCID: PMC6258006.
  24. 24. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. Epub 2007/12/08. pmid:18064739.
  25. 25. Arab L, Dhaliwal SK, Martin CJ, Larios AD, Jackson NJ, Elashoff D. Association between walnut consumption and diabetes risk in NHANES. Diabetes/metabolism research and reviews. 2018;34(7):e3031. Epub 2018/06/22. pmid:29927053; PubMed Central PMCID: PMC6220814.
  26. 26. Kim K, Melough MM, Vance TM, Noh H, Koo SI, Chun OK. Dietary Cadmium Intake and Sources in the US. Nutrients. 2018;11(1). Epub 2018/12/24. pmid:30577418; PubMed Central PMCID: PMC6356330.
  27. 27. Li T, Yu L, Yang Z, Shen P, Lin H, Shui L, et al. Associations of Diet Quality and Heavy Metals with Obesity in Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey (NHANES). Nutrients. 2022;14(19). Epub 2022/10/15. pmid:36235691; PubMed Central PMCID: PMC9571327.
  28. 28. Meier HCS, Sandler DP, Wilkerson J, Miller FW, Dinse GE, Parks CG. Hygiene Hypothesis Indicators and Prevalence of Antinuclear Antibodies in US Adolescents. Frontiers in immunology. 2022;13:789379. Epub 2022/02/15. pmid:35154106; PubMed Central PMCID: PMC8832391.
  29. 29. Fonseka CL, Hardman CS, Woo J, Singh R, Nahler J, Yang J, et al. Dengue virus co-opts innate type 2 pathways to escape early control of viral replication. Communications biology. 2022;5(1):735. Epub 2022/07/23. pmid:35869167; PubMed Central PMCID: PMC9306424.
  30. 30. Nasif WA, Mukhtar MH, Nour Eldein MM, Ashgar SS. Oxidative DNA damage and oxidized low density lipoprotein in Type II diabetes mellitus among patients with Helicobacter pylori infection. Diabetology & metabolic syndrome. 2016;8:34. Epub 2016/05/06. pmid:27148410; PubMed Central PMCID: PMC4855822.
  31. 31. Tian S, Wu L, Zheng H, Zhong X, Liu M, Yu X, et al. Dietary niacin intake in relation to depression among adults: a population-based study. BMC psychiatry. 2023;23(1):678. Epub 2023/09/19. pmid:37723526; PubMed Central PMCID: PMC10506255.
  32. 32. Ying H, Gao L, Liao N, Xu X, Yu W, Hong W. Association between niacin and mortality among patients with cancer in the NHANES retrospective cohort. BMC cancer. 2022;22(1):1173. Epub 2022/11/16. pmid:36376861; PubMed Central PMCID: PMC9661743.
  33. 33. Shen X, Yang L, Liu YY, Jiang L, Huang JF. Association between dietary niacin intake and cognitive function in the elderly: Evidence from NHANES 2011–2014. Food science & nutrition. 2023;11(8):4651–64. Epub 2023/08/14. pmid:37576033; PubMed Central PMCID: PMC10420858.
  34. 34. Zhang Y, Liu W, Zhang W, Cheng R, Tan A, Shen S, et al. Association between blood lead levels and hyperlipidemiais: Results from the NHANES (1999–2018). Frontiers in public health. 2022;10:981749. Epub 2022/09/27. pmid:36159291; PubMed Central PMCID: PMC9500574.
  35. 35. Zhang C, Cheng R, Ding J, Li X, Niu H, Li X. Serum Copper and Zinc Levels and Colorectal Cancer in Adults: Findings from the National Health and Nutrition Examination 2011–2016. Biological trace element research. 2022;200(5):2033–9. Epub 2021/07/21. pmid:34283364.
  36. 36. Dalmiglio C, Brilli L, Ciuoli C, Maino F, Valerio L, Sannino I, et al. Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors. Cancers. 2022;14(19). Epub 2022/10/15. pmid:36230491; PubMed Central PMCID: PMC9559209.
  37. 37. Wu H, Jackson CA, Wild SH, Jian W, Dong J, Gasevic D. Socioeconomic status and self-reported, screen-detected and total diabetes prevalence in Chinese men and women in 2011–2012: a nationwide cross-sectional study. Journal of global health. 2018;8(2):020501. Epub 2018/08/25. pmid:30140436; PubMed Central PMCID: PMC6076585 epidemiology of diabetes from Global MedEd/Astra Zeneca and on the Scottish diabetes register from Novo Nordisk. The authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no other competing interests.
  38. 38. Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, et al. Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study. Chest. 2021;160(3):1026–34. Epub 2021/04/12. pmid:33839084; PubMed Central PMCID: PMC8449007.
  39. 39. Kwon T, Lamster IB, Levin L. Current Concepts in the Management of Periodontitis. International dental journal. 2021;71(6):462–76. Epub 2021/11/30. pmid:34839889; PubMed Central PMCID: PMC9275292.
  40. 40. Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B Vitamins and Their Role in Immune Regulation and Cancer. Nutrients. 2020;12(11). Epub 2020/11/08. pmid:33158037; PubMed Central PMCID: PMC7693142.
  41. 41. Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infection and immunity. 2001;69(2):730–6. Epub 2001/02/13. pmid:11159961; PubMed Central PMCID: PMC97945.
  42. 42. Kim IJ, Blanke SR. Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Frontiers in cellular and infection microbiology. 2012;2:37. Epub 2012/08/25. pmid:22919629; PubMed Central PMCID: PMC3417592.
  43. 43. Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. An Overview of Helicobacter pylori VacA Toxin Biology. Toxins. 2016;8(6). Epub 2016/06/09. pmid:27271669; PubMed Central PMCID: PMC4926140.
  44. 44. Yamasaki E, Wada A, Kumatori A, Nakagawa I, Funao J, Nakayama M, et al. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. The Journal of biological chemistry. 2006;281(16):11250–9. Epub 2006/01/27. pmid:16436379.
  45. 45. Kaili. H. Study on the mechanism of Helicobacter pylori adhesion colonization in the pathogenesis of infection. Journal of Pathogen Biology. 2023;18(10):1223–5,30.(in Chinese).
    • 46. Jacobson EL, Giacomoni PU, Roberts MJ, Wondrak GT, Jacobson MK. Optimizing the energy status of skin cells during solar radiation. Journal of photochemistry and photobiology B, Biology. 2001;63(1–3):141–7. Epub 2001/10/31. pmid:11684461.
    • 47. Depeint F, Bruce WR, Shangari N, Mehta R, O’Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chemico-biological interactions. 2006;163(1–2):94–112. Epub 2006/06/13. pmid:16765926.
    • 48. Carron MA, Tran VR, Sugawa C, Coticchia JM. Identification of Helicobacter pylori biofilms in human gastric mucosa. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2006;10(5):712–7. Epub 2006/05/23. pmid:16713544.
    • 49. Sigal M, Rothenberg ME, Logan CY, Lee JY, Honaker RW, Cooper RL, et al. Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands. Gastroenterology. 2015;148(7):1392–404.e21. Epub 2015/03/01. pmid:25725293.
    • 50. Jang IA, Kim J, Park W. Endogenous hydrogen peroxide increases biofilm formation by inducing exopolysaccharide production in Acinetobacter oleivorans DR1. Scientific reports. 2016;6:21121. Epub 2016/02/18. pmid:26884212; PubMed Central PMCID: PMC4756669.
    • 51. Choi HJ, Jang SY, Hwang ES. High-Dose Nicotinamide Suppresses ROS Generation and Augments Population Expansion during CD8(+) T Cell Activation. Molecules and cells. 2015;38(10):918–24. Epub 2015/10/08. pmid:26442863; PubMed Central PMCID: PMC4625074.
    • 52. Song SB, Jang SY, Kang HT, Wei B, Jeoun UW, Yoon GS, et al. Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy. Molecules and cells. 2017;40(7):503–14. Epub 2017/07/25. pmid:28736426; PubMed Central PMCID: PMC5547220.
    • 53. Digby JE, Martinez F, Jefferson A, Ruparelia N, Chai J, Wamil M, et al. Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arteriosclerosis, thrombosis, and vascular biology. 2012;32(3):669–76. Epub 2012/01/24. pmid:22267479; PubMed Central PMCID: PMC3392598.
    • 54. Wuerch E, Urgoiti GR, Yong VW. The Promise of Niacin in Neurology. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. 2023;20(4):1037–54. Epub 2023/04/21. pmid:37084148; PubMed Central PMCID: PMC10457276.
    • 55. Zandi-Nejad K, Takakura A, Jurewicz M, Chandraker AK, Offermanns S, Mount D, et al. The role of HCA2 (GPR109A) in regulating macrophage function. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2013;27(11):4366–74. Epub 2013/07/25. pmid:23882124; PubMed Central PMCID: PMC3804742.
    • 56. Meliț LE, Mărginean CO, Mărginean CD, Mărginean MO. The Relationship between Toll-like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic. Journal of immunology research. 2019;2019:8197048. Epub 2019/03/14. pmid:30863783; PubMed Central PMCID: PMC6378784.